GreenLight Pharmaceuticals Ltd announced that it has received €1.8 million in an equity round of funding from new investor SOL Global Investments Corp. (CNSX:SOL) on January 2, 2019. The investor will acquire 25% stake in the company with an option to increase its stake to 51%. Pursuant to the transaction, Rob Reid and Michael Barnes will join the board seat of the company.